期刊
SCIENCE ADVANCES
卷 7, 期 33, 页码 -出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.abg5995
关键词
-
资金
- Blavatnik Biomedical Accelerator at Harvard University
COVID-19 continues to burden society worldwide, with severe presentations lacking specific treatments. Cell therapies, with their customizability and regenerative function, offer great potential in treating severe COVID-19 cases beyond lung issues. There are currently 89 cell therapy trials ongoing in the field of COVID-19.
Coronavirus disease 2019 (COVID-19) continues to burden society worldwide. Despite most patients having a mild course, severe presentations have limited treatment options. COVID-19 manifestations extend beyond the lungs and may affect the cardiovascular, nervous, and other organ systems. Current treatments are nonspecific and do not address potential long-term consequences such as pulmonary fibrosis, demyelination, and ischemic organ damage. Cell therapies offer great potential in treating severe COVID-19 presentations due to their customizability and regenerative function. This review summarizes COVID-19 pathogenesis, respective areas where cell therapies have potential, and the ongoing 89 cell therapy trials in COVID-19 as of 1 January 2021.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据